Russia approves Sputnik-Astra vaccine combined trials

Tribune News Service

Updated At : 02:06 PM Jul 28, 2021 IST

Unlock Exclusive Insights with The Tribune Premium

Take your experience further with Premium access. Thought-provoking Opinions, Expert Analysis, In-depth Insights and other Member Only Benefits

Yearly Premium ₹999 ₹349/Year

Yearly Premium $49 $24.99/Year

Moscow, July 27

Russia’s health officials have given a go-ahead to testing a combination of the AstraZeneca shot and the single-dose version of the domestically developed Sputnik V vaccine, according to the country’s registry of approved clinical trials.

The small study, scheduled to end in March next year, will enroll 150 volunteers and look at the mixed regimen’s safety and capability to trigger immune response. — AP

The Tribune, now published from Chandigarh, started publication on February 2, 1881, in Lahore (now in Pakistan). It was started by Sardar Dyal Singh Majithia, a public-spirited philanthropist, and is run by a trust comprising five eminent persons as trustees.

The Tribune, the largest selling English daily in North India, publishes news and views without any bias or prejudice of any kind. Restraint and moderation, rather than agitational language and partisanship, are the hallmarks of the newspaper. It is an independent newspaper in the real sense of the term.

The Tribune has two sister publications, Punjabi Tribune (in Punjabi) and Dainik Tribune (in Hindi).

Remembering Sardar Dyal Singh Majithia

Designed and developed by : SORTD

Unlock Exclusive Insights with The Tribune Premium

Suggested Articles